These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7338338)

  • 1. [Augmentation of specific anti-tumor immunity by immunization with xenogenized tumor cells and its application to the experimental cancer treatment (author's transl)].
    Okayasu T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):615-22. PubMed ID: 7338338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
    Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active immunotherapy of a 3-methylcholanthrene-induced rat tumor with Friend virus-infected (xenogenized) tumor cells.
    Okayasu T; Hosokawa M; Tanabe T; Kobayashi H
    Jpn J Cancer Res; 1986 Aug; 77(8):817-24. PubMed ID: 3093428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of viable tumor cells--comparison of immunogenicity between xenogenized tumor cells and BCG-tumor cell vaccine].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):908-15. PubMed ID: 4085970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide (author's transl)].
    Terashima M
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):495-9. PubMed ID: 6456215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor.
    Kobayashi H; Gotohda E; Hosokawa M; Kodama T
    J Natl Cancer Inst; 1975 Apr; 54(4):997-9. PubMed ID: 1127731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of tumor associated antigen expression during the regression phase of xenogenized tumor cell growth in vivo.
    Shibata T; Micallef M; Chiba I; Arisue M; Hosokawa M; Okada F; Takeichi N; Kobayashi H
    Anticancer Res; 1997; 17(3C):2135-40. PubMed ID: 9216677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The improved effects of specific active immunotherapy on a rat fibrosarcoma by antitumor drugs.
    Komatsumoto M; Hosokawa M; Okada F; Okayasu T; Tanabe T; Kobayashi H
    Cancer Immunol Immunother; 1991; 33(5):279-84. PubMed ID: 1714345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antigenicity of xenogenized tumor cells with special reference to amounts of virus-associated antigen (author's transl)].
    Yamaguchi H
    Hokkaido Igaku Zasshi; 1981 Jul; 56(4):439-48. PubMed ID: 7327520
    [No Abstract]   [Full Text] [Related]  

  • 11. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.
    Suzuki Y; Suzuki K; Hosokawa M; Kobayashi H
    Cancer Immunol Immunother; 1986; 22(3):204-10. PubMed ID: 3731206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia.
    Ben-Efraim S; Bizzini B; Relyveld EH
    Biomed Pharmacother; 2000 Jun; 54(5):268-73. PubMed ID: 10917465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
    Skornick Y; Kurman CC; Sindelar WF
    Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of transplanted rat tumors by immunization with identical tumor cells infected with Friend virus.
    Kobayashi H; Sendo F; Kaji H; Shirai T; Saito H; Takeichi N; Hosokawa M; Kodama T
    J Natl Cancer Inst; 1970 Jan; 44(1):11-9. PubMed ID: 11515021
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmentation of tumor cell immunogenicity by viruses--an approach to specific immunotherapy of cancer.
    Shoham J; Hirsch R; Zakay-Rones Z; Osband ME; Brennert HJ
    Nat Immun Cell Growth Regul; 1990; 9(3):165-72. PubMed ID: 2370876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.